Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd-Rüdiger Burmester

Showing results (11-20 of 171) with videos related to

Pageof 18
Sort By:
Blood|October 25, 2011
Prothrombin 20210G>A genotype and C-reactive protein levelBerthold Hoppe, Gerd-Rüdiger Burmester, Thomas Häupl
Joint Bone Spine|April 13, 2020
What will be the job of the rheumatologist in 2030?Martin Krusche, Johanna Mucke, Gerd-Rüdiger Burmester
Lancet (London, England)|March 1, 2005
Optimised glucocorticoid therapy: the sharpening of an old spearFrank Buttgereit, Gerd-Rüdiger Burmester, Brian J Lipworth
Zeitschrift Fur Rheumatologie|September 1, 2023
[Therapeutic antibodies in rheumatology]Fredrik N Albach, Gerd-Rüdiger Burmester, Johanna Mucke
Therapeutic Advances in Musculoskeletal Disease|October 18, 2021
The role of upadacitinib in the treatment of moderate-to-severe active rheumatoid arthritisAli Berkant Avci, Eugen Feist, Gerd Rüdiger Burmester
Deutsches Arzteblatt International|November 24, 2022
In ReplyJohanna Mucke, Hans-Uwe Simon, Gerd Rüdiger Burmester
Zeitschrift Fur Rheumatologie|July 8, 2021
[80 milestones in rheumatology from 80 years- III. 1980-2000]Gerd-Rüdiger Burmester, Joachim R Kalden, Thomas Rose
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 30, 2018
Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What's the Difference?Ali Berkant Avci, Eugen Feist, Gerd Rüdiger Burmester
Deutsches Arzteblatt International|April 12, 2022
Unusual Differential Diagnosis in Suspected MeningitisPhilipp Dittert, Kay Geert Hermann, Gerd Rüdiger Burmester
Nature Clinical Practice. Rheumatology|December 3, 2008
Inflammation, glucocorticoids and risk of cardiovascular diseaseFrank Buttgereit, Gerd-Rüdiger Burmester, Brian J Lipworth
Pageof 18

Showing results (11-20 of 171) with videos related to

Sort By:
Pageof 18
Blood|October 25, 2011
Prothrombin 20210G>A genotype and C-reactive protein levelBerthold Hoppe, Gerd-Rüdiger Burmester, Thomas Häupl
Joint Bone Spine|April 13, 2020
What will be the job of the rheumatologist in 2030?Martin Krusche, Johanna Mucke, Gerd-Rüdiger Burmester
Lancet (London, England)|March 1, 2005
Optimised glucocorticoid therapy: the sharpening of an old spearFrank Buttgereit, Gerd-Rüdiger Burmester, Brian J Lipworth
Zeitschrift Fur Rheumatologie|September 1, 2023
[Therapeutic antibodies in rheumatology]Fredrik N Albach, Gerd-Rüdiger Burmester, Johanna Mucke
Therapeutic Advances in Musculoskeletal Disease|October 18, 2021
The role of upadacitinib in the treatment of moderate-to-severe active rheumatoid arthritisAli Berkant Avci, Eugen Feist, Gerd Rüdiger Burmester
Deutsches Arzteblatt International|November 24, 2022
In ReplyJohanna Mucke, Hans-Uwe Simon, Gerd Rüdiger Burmester
Zeitschrift Fur Rheumatologie|July 8, 2021
[80 milestones in rheumatology from 80 years- III. 1980-2000]Gerd-Rüdiger Burmester, Joachim R Kalden, Thomas Rose
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 30, 2018
Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What's the Difference?Ali Berkant Avci, Eugen Feist, Gerd Rüdiger Burmester
Deutsches Arzteblatt International|April 12, 2022
Unusual Differential Diagnosis in Suspected MeningitisPhilipp Dittert, Kay Geert Hermann, Gerd Rüdiger Burmester
Nature Clinical Practice. Rheumatology|December 3, 2008
Inflammation, glucocorticoids and risk of cardiovascular diseaseFrank Buttgereit, Gerd-Rüdiger Burmester, Brian J Lipworth
Pageof 18